Home allergy testing company Nectar secures $16.5M in funding
The investment will support Nectar’s growth nationwide, fund clinical trials and help the company open a physical location.

The investment will support Nectar’s growth nationwide, fund clinical trials and help the company open a physical location.

Go to Source
2022-12-20 23:04